News | November 14, 2021
Alarming rise in diabetes amongst children and adolescents in India
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
These modules will act as a guide to doctors and health care workers to deal with post-Covid-19 issues
Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month
Results reinforce the well-established safety profile of Dupixent - the first-ever biologic medicine for atopic dermatitis currently approved for patients as young 6 years old
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Subscribe To Our Newsletter & Stay Updated
